These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1396728)

  • 1. Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida.
    Pfaller M; Riley J
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):152-6. PubMed ID: 1396728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans.
    Pfaller M; Riley J; Koerner T
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1067-70. PubMed ID: 2695329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of fluconazole resistance in Candida krusei.
    Orozco AS; Higginbotham LM; Hitchcock CA; Parkinson T; Falconer D; Ibrahim AS; Ghannoum MA; Filler SG
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2645-9. PubMed ID: 9756770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
    Yu PK; Moron-Espiritu LS; Lao AR
    mSystems; 2022 Dec; 7(6):e0069122. PubMed ID: 36383015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans.
    Park KS; Kang KC; Kim JH; Adams DJ; Johng TN; Paik YK
    J Antimicrob Chemother; 1999 May; 43(5):667-74. PubMed ID: 10382888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal effects of a 1,3,4-thiadiazole derivative determined by cytochemical and vibrational spectroscopic studies.
    Chudzik B; Bonio K; Dabrowski W; Pietrzak D; Niewiadomy A; Olender A; Pawlikowska-Pawlęga B; Gagoś M
    PLoS One; 2019; 14(9):e0222775. PubMed ID: 31568502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Antifungal Benzimidazole Derivative Inhibits Ergosterol Biosynthesis and Reveals Novel Sterols.
    Keller P; Müller C; Engelhardt I; Hiller E; Lemuth K; Eickhoff H; Wiesmüller KH; Burger-Kentischer A; Bracher F; Rupp S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6296-307. PubMed ID: 26248360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of plagiochin E alone and in combination with fluconazole on the ergosterol biosynthesis of Candida albicans.
    Sun LM; Lv BB; Cheng AX; Wu XZ; Lou HX
    Biol Pharm Bull; 2009 Jan; 32(1):36-40. PubMed ID: 19122277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
    Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
    Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination effects of phenolic compounds and fluconazole on the formation of ergosterol in Candida albicans determined by high-performance liquid chromatography/tandem mass spectrometry.
    Sun S; Gao Y; Ling X; Lou H
    Anal Biochem; 2005 Jan; 336(1):39-45. PubMed ID: 15582556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
    Löffler J; Einsele H; Hebart H; Schumacher U; Hrastnik C; Daum G
    FEMS Microbiol Lett; 2000 Apr; 185(1):59-63. PubMed ID: 10731607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole.
    Ghannoum MA; Spellberg BJ; Ibrahim AS; Ritchie JA; Currie B; Spitzer ED; Edwards JE; Casadevall A
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2029-33. PubMed ID: 7811014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
    Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P
    Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of cassia fistula extracts against fluconazole resistant strains of Candida species from HIV patients.
    Sony P; Kalyani M; Jeyakumari D; Kannan I; Sukumar RG
    J Mycol Med; 2018 Mar; 28(1):193-200. PubMed ID: 28838629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.
    Song JL; Lyons CN; Holleman S; Oliver BG; White TC
    Med Mycol; 2003 Oct; 41(5):417-25. PubMed ID: 14653518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug.
    Venkateswarlu K; Denning DW; Manning NJ; Kelly SL
    FEMS Microbiol Lett; 1995 Sep; 131(3):337-41. PubMed ID: 7557345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.